$MINM
MINIM, INC. Stock $minm

$minm Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010335 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$10.75M	$10.63M	$50.62M
YoY Change	-19.16%	1.44%	-8.66%
Cost Of Revenue	$8.143M	$8.513M	$38.70M
YoY Change	-10.6%	21.25%	2.12%
Gross Profit	$2.609M	$2.114M	$11.93M
YoY Change	-37.75%	-38.82%	-31.96%
Gross Profit Margin	24.27%	19.89%	23.56%
Selling, General & Admin	$5.050M	$4.868M	$21.15M
YoY Change	-1.03%	-2.23%	13.46%
% of Gross Profit	193.56%	230.32%	177.31%
Research & Development	$1.484M	$1.598M	$5.825M
YoY Change	-3.77%	-0.22%	-5.51%
% of Gross Profit	56.89%	75.58%	48.84%
Depreciation & Amortization	$230.0K	$220.5K	$403.0K
YoY Change	75.94%	-7.41%	-57.91%
% of Gross Profit	8.81%	10.43%	3.38%
Operating Expenses	$6.535M	$6.466M	$26.97M
YoY Change	-1.67%	-1.74%	8.75%
Operating Profit	-$3.925M	-$4.352M	-$15.05M
YoY Change	59.94%	39.23%	106.88%
Interest Expense	$145.0K	-$132.4K	$394.6K
YoY Change	-285.64%	242.52%	-274.42%
% of Operating Profit
Other Income/Expense, Net	-$145.0K	$2.300K	-$391.9K
YoY Change	85.65%	-111.55%	-435495.56%
Pretax Income	-$4.070M	-$4.482M	-$15.44M
YoY Change	60.73%	41.64%	338.18%
Income Tax		$39.32K	$112.3K
% Of Pretax Income
Net Earnings	-$4.070M	-$4.522M	-$15.55M
YoY Change	60.35%	41.87%	333.52%
Net Earnings / Revenue	-37.86%	-42.55%	-30.72%
Basic Earnings Per Share	-$2.16		-$0.34
Diluted Earnings Per Share	-$2.16	-$0.10	-$0.34
COMMON SHARES
Basic Shares Outstanding	47.19M shares	46.58M shares	46.40M shares
Diluted Shares Outstanding	1.880M shares		46.40M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$800.0K	$530.1K	$530.1K
YoY Change	-92.04%	-95.78%	-95.78%
Cash & Equivalents	$800.0K	$530.0K	$530.1K
Short-Term Investments
Other Short-Term Assets	$940.0K	$860.7K	$860.7K
YoY Change	-17.64%	-20.88%	-20.88%
Inventory	$22.77M	$25.42M	$25.42M
Prepaid Expenses
Receivables	$3.195M	$2.758M	$2.758M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$27.71M	$29.56M	$29.56M
YoY Change	-41.96%	-43.61%	-43.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$552.2K	$637.0K	$810.5K
YoY Change	-44.86%	-16.5%	-19.31%
Goodwill
YoY Change
Intangibles	$46.26K	$73.30K
YoY Change		-72.1%
Long-Term Investments
YoY Change
Other Assets	$514.2K	$511.8K	$511.8K
YoY Change	-20.34%	-6.05%	-6.05%
Total Long-Term Assets	$1.247M	$1.396M	$1.396M
YoY Change	-35.68%	-25.4%	-25.4%
TOTAL ASSETS
Total Short-Term Assets	$27.71M	$29.56M	$29.56M
Total Long-Term Assets	$1.247M	$1.396M	$1.396M
Total Assets	$28.95M	$30.96M	$30.96M
YoY Change	-41.72%	-42.98%	-42.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.336M	$2.837M	$2.837M
YoY Change	-34.99%	-77.23%	-77.23%
Accrued Expenses	$4.729M	$4.441M	$4.592M
YoY Change	-2.97%	-15.89%	-15.34%
Deferred Revenue
YoY Change
Short-Term Debt	$3.830M	$4.759M	$4.759M
YoY Change	-45.84%	-6.05%	-6.05%
Long-Term Debt Due	$1.000M		$1.000M
YoY Change	12836.61%		2820.56%
Total Short-Term Liabilities	$15.65M	$13.82M	$13.82M
YoY Change	-23.91%	-40.61%	-40.61%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$910.0K	$794.3K	$794.3K
YoY Change	82.08%	46.47%	46.47%
Total Long-Term Liabilities	$910.0K	$794.3K	$794.3K
YoY Change	82.08%	46.47%	46.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.65M	$13.82M	$13.82M
Total Long-Term Liabilities	$910.0K	$794.3K	$794.3K
Total Liabilities	$16.55M	$14.62M	$14.62M
YoY Change	-21.42%	-38.63%	-38.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$78.90M	-$74.80M
YoY Change		26.17%
Common Stock	$471.9K	$469.5K
YoY Change		2.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.40M	$16.34M	$16.34M
YoY Change
Total Liabilities & Shareholders Equity	$28.95M	$30.96M	$30.96M
YoY Change	-41.72%	-42.98%	-42.98%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$4.070M	-$4.522M	-$15.55M
YoY Change	60.35%	41.87%	333.52%
Depreciation, Depletion And Amortization	$230.0K	$220.5K	$403.0K
YoY Change	75.94%	-7.41%	-57.91%
Cash From Operating Activities	$1.300M	-$707.4K	-$12.20M
YoY Change	-130.15%	-83.39%	-14.52%
INVESTING ACTIVITIES
Capital Expenditures	$6.330K	$24.05K	$276.7K
YoY Change	-105.5%	-151.09%	-146.65%
Acquisitions
YoY Change
Other Investing Activities	-$120.0K	-$72.37K	-$418.4K
YoY Change	-23.22%		371.59%
Cash From Investing Activities	-$128.5K	-$96.41K	-$695.0K
YoY Change	-52.67%	104.82%	1.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$945.4K	-103.9K	$824.8K
YoY Change	-54.15%	-94.77%	-96.88%
NET CHANGE
Cash From Operating Activities	$1.300M	-707.4K	-$12.20M
Cash From Investing Activities	-$128.5K	-96.41K	-$695.0K
Cash From Financing Activities	$945.4K	-103.9K	$824.8K
Net Change In Cash	$2.117M	-907.6K	-$12.07M
YoY Change	-183.96%	-85.58%	-204.97%
FREE CASH FLOW
Cash From Operating Activities	$1.300M	-$707.4K	-$12.20M
Capital Expenditures	$6.330K	$24.05K	$276.7K
Free Cash Flow	$1.294M	-$731.4K	-$12.48M
YoY Change	-130.82%	-82.64%	-8.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001467761
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2021Q4	us-gaap	Bridge Loan BridgeLoan		usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	integer
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	MINM	Federal Tax Expense Benefit FederalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	MINM	Federal Tax Expense Benefit FederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4880663	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	MINM	Increase Decrease In Expiration IncreaseDecreaseInExpiration		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-37649
CY2022	dei	Entity Registrant Name EntityRegistrantName	MINIM, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2621506
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	848 Elm Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Manchester
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NH
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	03101
CY2022	dei	City Area Code CityAreaCode	(617)
CY2022	dei	Local Phone Number LocalPhoneNumber	423-1072
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2022	dei	Trading Symbol TradingSymbol	MINM
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	9600000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47188378	shares
CY2022	dei	Auditor Firm AuditorFirmId	49
CY2022	dei	Auditor Name AuditorName	RSM US LLP
CY2022	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530110	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12570445	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	138331	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	236819	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2758406	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	25415206	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	33891287	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	360735	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	587885	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	29564457	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	52430280	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636973	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	762818	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173480	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	241626	usd
CY2021Q4	us-gaap	Goodwill Goodwill	58872	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73301	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	262698	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511795	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	544738	usd
CY2022Q4	us-gaap	Assets Assets	30960006	usd
CY2021Q4	us-gaap	Assets Assets	54301032	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4758663	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	5065074	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2837191	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12458246	usd
CY2022Q4	us-gaap	Bridge Loan BridgeLoan	1000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	34237	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150968	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	143486	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4440724	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5279917	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633542	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	291296	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13821088	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23272256	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22512	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98811	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	771738	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	443452	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14615338	usd
CY2021Q4	us-gaap	Liabilities Liabilities	23814519	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46949240	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46949240	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45885043	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45885043	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	469492	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	458850	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90710030	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89313273	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74834854	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59285610	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16344668	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	30486513	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30960006	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54301032	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55422526	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	38695605	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	36504874	usd
CY2022	us-gaap	Gross Profit GrossProfit	11926538	usd
CY2021	us-gaap	Gross Profit GrossProfit	18917652	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15022638	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	13747959	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6124034	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4889702	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5824906	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6164362	usd
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	3955626	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	26971578	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	20846397	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15045040	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1928745	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	457	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	44169	usd
CY2022	us-gaap	Interest Expense InterestExpense	394615	usd
CY2021	us-gaap	Interest Expense InterestExpense	270407	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	20000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2302	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-391856	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-206149	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15436896	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2134894	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112348	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63773	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2198667	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46399137	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39761121	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	7790470	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2198667	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1167724	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22730049	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	996937	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	30486513	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	236804	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1170595	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16344668	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2198667	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	837228	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	957490	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	172060	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	145143	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71401	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41586	usd
CY2022	MINM	Amortization Of Sales Contract Costs AmortizationOfSalesContractCosts	75514	usd
CY2021	MINM	Amortization Of Sales Contract Costs AmortizationOfSalesContractCosts	32343	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1170595	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	996937	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	58872	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	67415	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-98489	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	63217	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1785566	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	643671	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	20000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2220746	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4259454	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6690515	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18030117	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-227150	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	188766	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-63044	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	92161	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9621054	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	862453	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-839265	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2261266	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	670532	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	661826	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-172659	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-145410	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12170073	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14272267	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	276665	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	593120	usd
CY2022	MINM	Certification Costs Incurred And Capitalized CertificationCostsIncurredAndCapitalized	418352	usd
CY2021	MINM	Certification Costs Incurred And Capitalized CertificationCostsIncurredAndCapitalized	88708	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-695017	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-681828	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	-377811	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	5166289	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	2442246	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	142801	usd
CY2022	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	34237	usd
CY2021	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	26232	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	236803	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1167724	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	22730049	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	824755	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	26452783	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12040335	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11498688	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13070445	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1571757	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030110	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13070445	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	394615	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	270407	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	88348	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	63773	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530110	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12570445	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1030110	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13070445	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	530000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15500000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12200000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74800000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zlyiJnh1zh0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zfAJVZuBM3s9">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, restricted cash and accounts receivable. Substantially all the Company’s cash and cash equivalents and restricted cash are held at one financial institution, Silicon Valley Bank, which was placed into receivership by the FDIC on March 9, 2023. On March 10, 2023, the Silicon Valley Bank depositor accounts and loan facilities, including the Company’s bank accounts and line of credit, were transferred to Silicon Valley Bridge Bank. Through Silicon Valley Bridge Bank, the Company’s bank balances are fully insured by the FDIC and the line of credit facility remains operational, allowing the Company to draw from it as required. The Company has not experienced any credit losses on its cash and cash equivalents and restricted cash through December 31, 2022 and has not experienced any credit losses as of the date of filing this Form 10-K</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, two customers accounted for 10% or greater individually, and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zsBxeG4Ugch7" title="Concentration risk, percentage">87</span>% in the aggregate of the Company’s total net sales. For the year ended December 31, 2021, two customers accounted for 10% or greater individually, and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zEaoRvSmlSyh" title="Concentration risk, percentage">92</span>% in the aggregate of the Company’s total net sales. Accounts receivable are unsecured and the Company does not require collateral; however, the Company does assess the collectability of accounts receivable based on a number of factors, including past transaction history with, and the creditworthiness of, the customer. Accordingly, the Company is exposed to credit risk associated with accounts receivable. At December 31, 2022, two customers with an accounts receivable balance of 10% or greater individually accounted for a combined <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zZ8xQmx7Wz5d" title="Concentration risk, percentage">75</span>% of the Company’s accounts receivable. At December 31, 2021, four customers with an accounts receivable balance of 10% or greater individually accounted for a combined <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zSJPWrUXda8c">86</span>% of the Company’s accounts receivable. To reduce risk, the Company closely monitors the amounts due from its customers and assesses the financial strength of its customers through a variety of methods that include, but are not limited to, engaging directly with customer operations and leadership personnel, visiting customer locations to observe operating activities, and assessing customer longevity and reputation in the marketplace. As a result, the Company believes that its accounts receivable credit risk exposure is limited.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company depends on many third-party suppliers for key components contained in its product offerings. For some of these components, the Company may only use a single source supplier, in part due to the lack of alternative sources of supply. During 2022 and 2021, the Company had two and one suppliers that provided <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--TwoSuppliersMember_zO9qt0qxaZG6" title="Concentration risk, percentage"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--TwoSuppliersMember_zbDOWHpTEs38" title="Concentration risk, percentage">93</span></span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--OneSupplierMember_zMKNwGoWpzZf" title="Concentration risk percentage"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--OneSupplierMember_zQVBaGnpwqcf" title="Concentration risk percentage">97</span></span>%, respectively, of the Company’s purchased inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	59000	usd
CY2022Q4	MINM	Capitalized Implementation Costs CapitalizedImplementationCosts	0	usd
CY2021Q4	MINM	Capitalized Implementation Costs CapitalizedImplementationCosts	0	usd
CY2022Q4	MINM	Net Of Accumulated Amortization Of Certification Costs NetOfAccumulatedAmortizationOfCertificationCosts	402000	usd
CY2021Q4	MINM	Net Of Accumulated Amortization Of Certification Costs NetOfAccumulatedAmortizationOfCertificationCosts	297000	usd
CY2022Q4	MINM	Net Of Accumulated Amortization For Longterm Insurance Policies NetOfAccumulatedAmortizationForLongtermInsurancePolicies	71000	usd
CY2021Q4	MINM	Net Of Accumulated Amortization For Longterm Insurance Policies NetOfAccumulatedAmortizationForLongtermInsurancePolicies	142000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-2198667	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46399137	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39761121	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46399137	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39761121	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	907945	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	799456	shares
CY2022Q4	MINM	Sales Return Accrual SalesReturnAccrual	982000	usd
CY2021Q4	MINM	Sales Return Accrual SalesReturnAccrual	1600000	usd
CY2022Q4	MINM	Accrual Promotion Rebate AccrualPromotionRebate	0	usd
CY2021Q4	MINM	Accrual Promotion Rebate AccrualPromotionRebate	175000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4000000.0	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2800000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	452000	usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	334000	usd
CY2022	MINM	Public Offerings And Private Placements Disclosure Text Blcok PublicOfferingsAndPrivatePlacementsDisclosureTextBlcok	<p id="xdx_808_ecustom--PublicOfferingsAndPrivatePlacementsDisclosureTextBlcok_z4Ln0awUmbF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(3) <span id="xdx_820_zS6822evj7qb">PUBLIC OFFERINGS AND PRIVATE PLACEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company entered into an underwriting agreement with B. Riley Securities, Inc., as representative (the “Representative”) of the several underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210727__20210728__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zk2zDx6mWLe3" title="Sale of stock, number of stock issued">10,000,000</span> shares of the Company’s Common Stock, to the Underwriters (the “Public Offering”). The shares of Common Stock were sold to the public at an offering price of $<span id="xdx_905_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20210728__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zs5xbrHNjdZg" title="Sale of stock price per share">2.50</span> per share and were purchased by the Underwriters from the Company at a price of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20210728__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zVZnq0Kma6Aj" title="Sale of stock price per share">2.32715</span> per share. On August 2, 2021, the Company received $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20210801__20210802__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zlHg8OGlOyy7" title="Proceeds from sale of common stock">22.7</span> million in aggregate net proceeds after deducting Underwriters’ discounts, commissions, and other offering expenses after issuing <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_c20210802__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKMUp6qLWYBb" title="Number of common stock issued">10,000,000</span> shares of the Company’s Common Stock through the Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 31pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	262698	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1400000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2758406	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4880663	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633542	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	291296	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	771738	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	443452	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	734748	usd
CY2022	MINM	Contract With Customer Liability Revenue Recognized Billings ContractWithCustomerLiabilityRevenueRecognizedBillings	1120627	usd
CY2022	MINM	Revenue Recognized RevenueRecognized	450095	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1405280	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55422526	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	55422526	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	125000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	397133	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	684386	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5842251	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3919503	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19175822	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	29287398	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	25415206	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	33891287	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	4200000	usd
CY2021Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	4500000	usd
CY2022Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	0	usd
CY2021Q4	us-gaap	Other Inventory In Transit OtherInventoryInTransit	6300000	usd
CY2022Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	2500000	usd
CY2021Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	800000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2489750	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2213084	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1852777	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1450266	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636973	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	762818	usd
CY2022	us-gaap	Depreciation Depreciation	403000	usd
CY2021	us-gaap	Depreciation Depreciation	255000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	316838	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	243537	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73301	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	439273	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	176575	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35604	usd
CY2022	us-gaap	Lease Cost LeaseCost	211101	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	40054	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	17346	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	15901	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73301	usd
CY2022Q4	MINM	Accrued Inventory Purchases Current And Noncurrent AccruedInventoryPurchasesCurrentAndNoncurrent	24901	usd
CY2021Q4	MINM	Accrued Inventory Purchases Current And Noncurrent AccruedInventoryPurchasesCurrentAndNoncurrent	287571	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	430358	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	210495	usd
CY2022Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	290588	usd
CY2021Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	229597	usd
CY2022Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	1650000	usd
CY2021Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	1588025	usd
CY2022Q4	MINM	Accrued Sales Allowances Current And Noncurrent AccruedSalesAllowancesCurrentAndNoncurrent	1226856	usd
CY2021Q4	MINM	Accrued Sales Allowances Current And Noncurrent AccruedSalesAllowancesCurrentAndNoncurrent	1958050	usd
CY2022Q4	MINM	Accrued Sales And Use Tax Current And Noncurrent AccruedSalesAndUseTaxCurrentAndNoncurrent	113200	usd
CY2021Q4	MINM	Accrued Sales And Use Tax Current And Noncurrent AccruedSalesAndUseTaxCurrentAndNoncurrent	50916	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	704821	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	955263	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4440724	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	5279917	usd
CY2021Q4	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	9000	usd
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	5000	usd
CY2021	us-gaap	Lease Cost LeaseCost	187897	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	181361	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	152293	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	29740	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	172730	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	145410	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	103914	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	299821	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	155379	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	22794	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	178173	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4693	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	173480	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150968	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22512	usd
CY2022Q4	MINM	Future Royalty Payments Due In Year One FutureRoyaltyPaymentsDueInYearOne	6850000	usd
CY2022Q4	MINM	Future Royalty Payments Due In Two Years FutureRoyaltyPaymentsDueInTwoYears	7100000	usd
CY2022Q4	MINM	Future Royalty Payments Due In Three Years FutureRoyaltyPaymentsDueInThreeYears	7100000	usd
CY2022Q4	MINM	Annual Royalty Payment AnnualRoyaltyPayment	21050000	usd
CY2022	us-gaap	Royalty Expense RoyaltyExpense	6600000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	6350000	usd
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46949240	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45885043	shares
CY2022	MINM	Stock Option Exercise Price Percentage StockOptionExercisePricePercentage	0.10	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3098163	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.16
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2.43	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	716258	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.48
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	814005	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.45
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	635842	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.28
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2364574	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.47
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0.42	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	430815	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.55
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	960591	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.47
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	973168	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.87
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	697884	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.57
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y10M24D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.00
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	140000	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1300000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	710000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1000000.0	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	536000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y14D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.428	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.758	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.003	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.012	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1223893	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.24
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1223893	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.24
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	851992	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.62
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	633282	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.84
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	329726	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1112877	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.95
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1170595	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	996937	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	32069	usd
CY2021	MINM	State And Local Tax Expense Benefit StateAndLocalTaxExpenseBenefit	32069	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	31704	usd
CY2021	MINM	Foreign Tax Expense Benefit ForeignTaxExpenseBenefit	31704	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	63773	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63773	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	59846	usd
CY2022	MINM	State And Local Tax Expense Benefit StateAndLocalTaxExpenseBenefit	59846	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	52502	usd
CY2022	MINM	Foreign Tax Expense Benefit ForeignTaxExpenseBenefit	52502	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	112348	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112348	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1234710	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	889821	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	566403	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	357920	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	484728	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	266665	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	45522	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14742578	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15195123	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	39311	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	60059	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	120661	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	65014	usd
CY2022Q4	MINM	Deferred Tax Assets Interest Expense Other DeferredTaxAssetsInterestExpenseOther	187990	usd
CY2021Q4	MINM	Deferred Tax Assets Interest Expense Other DeferredTaxAssetsInterestExpenseOther	74931	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17839656	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16491780	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17839656	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16491780	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	22100000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.20	pure
CY2022	MINM	Increase Decrease In State Income Taxes IncreaseDecreaseInStateIncomeTaxes	1	usd
CY2021	MINM	Increase Decrease In State Income Taxes IncreaseDecreaseInStateIncomeTaxes	-2	usd
CY2022	MINM	Increase Decrease In Change In Valuation Allowance IncreaseDecreaseInChangeInValuationAllowance	9	usd
CY2021	MINM	Increase Decrease In Change In Valuation Allowance IncreaseDecreaseInChangeInValuationAllowance	5	usd
CY2022	MINM	Increase Decrease In Expiration IncreaseDecreaseInExpiration	-13	usd
CY2022	MINM	Increase Decrease In Expiration Of Stock Options IncreaseDecreaseInExpirationOfStockOptions	-1	usd
CY2021	MINM	Increase Decrease In Expiration Of Stock Options IncreaseDecreaseInExpirationOfStockOptions	-14	usd
CY2022	MINM	Increase Decrease In Permanent Differences IncreaseDecreaseInPermanentDifferences	-1	usd
CY2021	MINM	Increase Decrease In Permanent Differences IncreaseDecreaseInPermanentDifferences	-4	usd
CY2022	MINM	Increase Decrease In Federal And State Rates IncreaseDecreaseInFederalAndStateRates	1	usd
CY2021	MINM	Increase Decrease In Federal And State Rates IncreaseDecreaseInFederalAndStateRates	3	usd
CY2022	MINM	Increase Decrease In Effective Income Tax Rate IncreaseDecreaseInEffectiveIncomeTaxRate	-0.01	pure
CY2021	MINM	Increase Decrease In Effective Income Tax Rate IncreaseDecreaseInEffectiveIncomeTaxRate	-0.02	pure
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	27000	usd
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.25	pure
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	179000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	23000	usd
CY2022Q4	us-gaap	Area Of Land AreaOfLand	2656
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	33000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	30000	usd
CY2023Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-25
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2021Q4	MINM	Common Stock Shares Authorized Pro Forma CommonStockSharesAuthorizedProForma	60000000	shares
CY2022Q4	MINM	Common Stock Issued And Outstanding CommonStockIssuedAndOutstanding	46949240	shares
CY2022Q4	MINM	Common Stock Issued And Outstanding Pro Forma CommonStockIssuedAndOutstandingProForma	1877970	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2022	MINM	Basic And Diluted Net Loss Per Share Pro Forma BasicAndDilutedNetLossPerShareProForma	-8.38
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46399137	shares
CY2022	MINM	Weighted Average Number Of Shares Outstanding Basic And Diluted Pro Forma WeightedAverageNumberOfSharesOutstandingBasicAndDilutedProForma	1855965	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
minm-20221231_cal.xml	Edgar Link	unprocessable
minm-20221231_lab.xml	Edgar Link	unprocessable
0001493152-23-010335-index-headers.html	Edgar Link	pending
0001493152-23-010335-index.html	Edgar Link	pending
0001493152-23-010335.txt	Edgar Link	pending
0001493152-23-010335-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
minm-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
minm-20221231_def.xml	Edgar Link	unprocessable
minm-20221231_pre.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MINM
MINIM, INC. Stock $minm

2023 Q1 Form 10-K Financial Statement

#000149315223010335 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MINM MINIM, INC. Stock $minm

2023 Q1 Form 10-K Financial Statement

#000149315223010335 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MINM
MINIM, INC. Stock $minm